secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-06-20T23:59:59+00:00
Accession:  0001799191-23-000027
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

The Oncology Institute shareholders elect all nine directors, ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- 64,996,623 shares voted (~86.4% of outstanding) at June 15 annual meeting.
- All nine director nominees elected with majority support; three nominees had ~13M votes withheld.
- Ratification of BDO USA as independent auditor for FY 2023 passed with 64.3M for, 444k against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/0001799191-23-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000027/toi-20230615.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer